Vol. 20 No. 2 (2021)
Original Articles

Multiresistance and endemic status of Corynebacterium striatum associated with nosocomial infections: a critical situation in Intensive Care Units and varied wards of a tertiary care hospital, Rio de Janeiro metropolitan area, Brazil

Published 2022-01-04

Keywords

  • Corynebacterium striatum,
  • Multidrug resistance,
  • Nosocomial infections,
  • Virulence,
  • Endemic

How to Cite

1.
F. Silva CM, F. Mota H, de O. Cabra F, V. Farias Y, M. Dimas S, S. de Santana G, N. M. de Gusmão L, A. Nogueira B, N. Ramos J, de Souza MC, de S. Leão R, G. de Oliveira MV, S. dos Santos L, Mattos-Guaraldi AL, de Souza C. Multiresistance and endemic status of Corynebacterium striatum associated with nosocomial infections: a critical situation in Intensive Care Units and varied wards of a tertiary care hospital, Rio de Janeiro metropolitan area, Brazil. BJHBS [Internet]. 2022 Jan. 4 [cited 2024 Sep. 28];20(2):114-28. Available from: https://bjhbs.hupe.uerj.br/bjhbs/article/view/34

Abstract

Nowadays, Corynebacterium striatum has been reported as etiologic agent of mild to severe hospital-acquired infections, including patients undergoing endotracheal intubation with fatal outcome. A continuous survey of infections due multi-drug-resistant (MDR) C. striatum in South American countries remains necessary. This retrospective and prospective study aimed to analyze clinical-microbiological features of C. stri-atum clinical isolates from patients attended at a Brazilian tertiary care hospital, during a nine-year period. C. striatum strains (n=130) were isolated from infected patients attended at twenty nosocomial wards, mainly of tracheal aspirate (n=53) and blood and/or intravenous catheter (n=21/n=13). Notably, original cases of nosocomial infections due to C. striatum were verified in children making use of invasive devices, includ-ing one fatal neonatal case, in addition to a fatal respiratory infection in patient with cystic fibrosis, as well as urinary tract infections of kidney transplant recipients. Most of C. striatum strains expressed MDR profiles (88.46%). Emergence of vancomycin (1.90%) and linezolid (7.41%) resistance was verified among MDR and non-MDR-strains. In conclusion, endemic condition with wide dissemination among hospital wards of varied types of infections due to MDR and non-MDR C. striatum strains expressing heterogenic virulence potential and genetic features may occur in hospital units.

Metrics

Metrics Loading ...

References

  1. Baio PVP, Mota HF, Freitas AD, et al. Clonal multidrug-resistant Corynebacterium striatum within a nosocomial environment, Rio de Janeiro, Brazil. Mem Inst Oswaldo Cruz. 2013 Feb;108(1):23–9.
  2. Parte AC. LPSN – List of Prokaryotic names with Standing in Nomenclature (bacterio.net), 20 years on. Vol. 68, International Journal of Systematic and Evolutionary Microbiology, Microbiology Society. 2018:1825–9.
  3. Zasada AA, Mosiej E. Contemporary microbiology and identification of Corynebacteria spp. causing infections in human. Lett Appl Microbiol. 2018 Jun;66(6):472–83.
  4. Renom F, Gomila M, Garau M, et al. Respiratory infection by Corynebacterium striatum: epidemiological and clinical determinants. New Microbes New Infect. 2014 Jul;2(4):106–14.
  5. Camello T, Mattos-Guaraldi A, Duarte F, et al., Nondiphtherial Corynebacterium species isolated from clinical specimens of patients in a University Hospital, Rio de Janeiro, Brazil. Braz J Microbiol. 2003 Apr;34.
  6. Martins C, Faria L, Souza M, Camello T, et al. Microbiological and host features associated with corynebacteriosis in cancer patients: a five-year study. Mem Inst Oswaldo Cruz. 2009 Sep;104(6):905–13.
  7. Louredo LS, Ramos JN, Peixoto RS, et al. Corynebacterium ulcerans isolates from humans and dogs: fibrinogen, fibronectin and collagen-binding, antimicrobial and PFGE profiles. 2014.
  8. Carvalho RV de, Lima FF da S, Santos CS dos, et al. Central venous catheter-related infections caused by Corynebacterium amycolatum and other multiresistant non-diphtherial corynebacteria in paediatric oncology patients. Braz J Infect Dis. 2018;22(4):347–51.
  9. Alibi S, Ferjani A, Boukadida J, et al. Occurrence of Corynebacterium striatum as an emerging antibiotic-resistant nosocomial pathogen in a Tunisian hospital. Sci Rep. 2017 Aug 28;7(1):9704.
  10. Otsuka Y, Ohkusu K, Kawamura Y, et al. Emergence of multidrug-resistant Corynebacterium striatum as a nosocomial pathogen in long-term hospitalized patients with underlying diseases. Diagn Microbiol Infect Dis. 2006 Feb;54(2):109–14.
  11. Verroken A, Bauraing C, Deplano A, et al. Epidemiological investigation of a nosocomial outbreak of multidrug-resistant Corynebacterium striatum at one Belgian university hospital. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2014 Jan;20(1):44–50.
  12. Wong KY, Chan YC, Wong CY. Corynebacterium striatum as an emerging pathogen. J Hosp Infect. 2010 Dec;76(4):371–2.
  13. Weiss K, Laverdière M, Rivest R. Comparison of antimicrobial susceptibilities of Corynebacterium species by broth microdilution and disk diffusion methods. Antimicrob Agents Chemother. 1996 Apr;40(4):930–3.
  14. Oliva A, Belvisi V, Iannetta M, et al. Pacemaker lead endocarditis due to multidrug-resistant Corynebacterium striatum detected with sonication of the device. J Clin Microbiol. 2010 Dec;48(12):4669–71.
  15. Roy M, Ahmad S. Rare case of Corynebacterium striatum septic arthritis. BMJ Case Rep. 2016 Sep 23;2016.
  16. Daisuke U, Oishi T, Yamane K, et al. Corynebacterium striatum Bacteremia Associated with a Catheter-Related Blood Stream Infection. Case Rep Infect Dis. 2017;2017:2682149.
  17. Moore K, Hall V, Paull A, et al. Surface bacteriology of venous leg ulcers and healing outcome. J Clin Pathol. 2010 Sep;63(9):830–4.
  18. Campanile F, Carretto E, Barbarini D, et al. Clonal multidrug-resistant Corynebacterium striatum strains, Italy. Emerg Infect Dis. 2009 Jan;15(1):75–8.
  19. Silva-Santana G, Silva CMF, Olivella JGB, et al. Worldwide survey of Corynebacterium striatum increasingly associated with human invasive infections, nosocomial outbreak, and antimicrobial multidrug-resistance, 1976–2020. Arch Microbiol. 2021 Jul 1;203(5):1863–80.
  20. Werth BJ, Hahn WO, Butler-Wu SM, et al. Emergence of High-Level Daptomycin Resistance in Corynebacterium striatum in Two Patients with Left Ventricular Assist Device Infections. Microb Drug Resist Larchmt N. 2016 Apr;22(3):233–7.
  21. Ramos JN, Souza C, Faria YV, et al. Bloodstream and catheter-related infections due to different clones of multidrug-resistant and biofilm producer Corynebacterium striatum. BMC Infect Dis. 2019 Jul 29;19(1):672.
  22. Mattos-Guaraldi AL, Guimarães LC, Santos CS, et al. Draft Genome Sequence of Corynebacterium striatum 1961 BR-RJ/09, a Multidrug-Susceptible Strain Isolated from the Urine of a Hospitalized 37-Year-Old Female Patient. Genome Announc. 2015 Aug 6;3(4).
  23. Souza C de, Faria YV, Sant’Anna L de O, et al. Biofilm production by multiresistant Corynebacterium striatum associated with nosocomial outbreak. Mem Inst Oswaldo Cruz. 2015 Apr;110(2):242–8.
  24. CLSI (2019) Performance standards for antimicrobial susceptibility testing. 29th edn, PA: Clinical and Laboratory Standards Institute. 29th edn. Wayne. doi: 10.1016/s0196-4399(01)88009-0.
  25. Magiorakos, A.P., A. Srinivasan, R.B. Carey, Y., et al. 2012. Multidrugresistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 18:268–28.
  26. Agência Nacional de Vigilância Sanitária (ANVISA) (2014) Controle de Infecção em Serviços da Saúde. Rio de Janeiro http://www.anvisa.gov.br/servicosaude/controle/legis.htm. Accessed 4 Jan 2018.
  27. Agência Nacional de Vigilância Sanitária (ANVISA) (2007) Controle de Infecção em Serviços da Saúde. Rio de Janeiro. http://www.anvis a.gov.br/servi cosau de/contr ole/renis s/manua l%20_controlebacterias.pdf. Accessed 15 Feb 2018
  28. Bandyopadhyay S, Bergholte J, Blackwell CD, et al., Risk of Serious Bacterial Infection in Children With Fever Without a Source in the Post–Haemophilus influenzae Era When Antibiotics Are Reserved for Culture-Proven Bacteremia. Arch Pediatr Adolesc Med. 2002 May 1;156(5):512–7.
  29. Severo CB, Guazzelli LS, Barra MB, et al. Multiple pulmonary nodules caused by Corynebacterium striatum in an immunocompetent patient. Rev Inst Med Trop Sao Paulo. 2014 Feb;56(1):89–91.
  30. Suh JW, Ju Y, Lee CK, et al. Molecular epidemiology and clinical significance of Corynebacterium striatum isolated from clinical specimens. Infect Drug Resist. 2019;12:161–71.
  31. García-Crespo D, Navas J, Gradillas G, et al., Technical note: molecular typing of Corynebacterium bovis isolates by pulsed-field gel electrophoresis. J Dairy Sci. 2005 May;88(5):1705–7.
  32. Papazian L, Klompas M, Luyt C-E. Ventilator-associated pneumonia in adults: a narrative review. Intensive Care Med. 2020 May;46(5):888–906.
  33. Clariot S, Constant O, Lepeule R, et al. Clinical relevance and impact of Corynebacterium isolation in lower respiratory tract of critically ill patients requiring mechanical ventilation. Infection. 2020 Jun;48(3):413–20.
  34. Chauvelot P, Ferry T, Tafani V, et al. Bone and Joint Infection Involving Corynebacterium spp.: From Clinical Features to Pathophysiological Pathways. Front Med. 2020;7:539501.
  35. Gomes JÁP, Frizon L, Demeda VF. Ocular Surface Microbiome in Health and Disease. Asia-Pac J Ophthalmol Phila Pa. 2020 Dec;9(6):505–11.
  36. Qin L, Sakai Y, Bao R, et al. Characteristics of Multidrug-Resistant Corynebacterium spp. Isolated from Blood Cultures of Hospitalized Patients in Japan. Jpn J Infect Dis. 2017 Mar 24;70(2):152–7.
  37. Rasmussen M, Mohlin AW, Nilson B. From contamination to infective endocarditis-a population-based retrospective study of Corynebacterium isolated from blood cultures. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol. 2020 Jan;39(1):113–9.
  38. Superti SV, Martins D de S, Caierão J, et al. Corynebacterium striatum infecting a malignant cutaneous lesion: the emergence of an opportunistic pathogen. Rev Inst Med Trop Sao Paulo. 2009 Apr;51(2):115–6.
  39. Souza C de, Mota HF, Faria YV, et al. Resistance to Antiseptics and Disinfectants of Planktonic and Biofilm-Associated Forms of Corynebacterium striatum. Microb Drug Resist Larchmt N. 2020 Dec;26(12):1546–58.
  40. Olender A. Antibiotic resistance and detection of the most common mechanism of resistance (MLSB) of Opportunistic Corynebacterium’, Chemotherapy, 59, pp. 294–306. doi: 10.1159/000357467.